Marc Rubin

Dr. Marc Rubin is Exectutive Chairman of Titan Pharmaceuticals, Inc. Until
February 2007, Dr. Rubin served as Head of Global Research and Development for
Bayer Schering Pharma, as well as a member of the Executive Committee of Bayer
Healthcare and the Board of Management of Bayer Schering Pharma. Prior to the
merger of Bayer Pharmaceuticals and Schering AG in June 2006, Dr. Rubin was a
member of the Executive Board of Schering AG since joining such company in
October 2003, as well as Chairman of Schering Berlin Inc. and President of
Berlex Pharmaceuticals, a division of Schering AG. From 1990 until August 2003,
Dr. Rubin was employed by GlaxoSmithKline where he held positions of
responsibility in global clinical and commercial development, overseeing
programs in the United States, Europe, Asia and Latin America. From 2001 through
2003, he was Senior Vice President of Global Clinical Pharmacology & Discovery
Medicine. Dr. Rubin holds an MD from Cornell University Medical College. He
currently serves on the Board of Directors of Medarex, Inc.